As a dual blockade of the PD-1/TIGIT ICPs, ZG005 showed sustained occupancy of both targets and was able to specifically inhibit their pathways simultaneously, resulting in synergistic effects and enhanced ability of the immune system to kill tumor cells. The gene discussed is TIGIT; the disease is neoplasm.